Saturday 17 October 2026 Export NBIX’s income statement to Excel — free account

Neurocrine Biosciences, Inc.

NBIX Healthcare Drug Manufacturers Specialty & Generic

Neurocrine Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 21.4% from fiscal 2024. In the quarter to June 2026, revenue grew 39.5%, EPS grew 31.2% and free cash flow grew 43.7%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for five.

135.71 1.24 −0.91%

Follow NBIX

Alert me

Market cap: $13.9B
P/E: 19.2×
Fwd P/E: 30.5×
Dividend yield: —
F-score: 7/9
Altman Z: 7.80
Beneish M: −2.64
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	22.09%	22.50%	16.38%	14.96%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	6	7	7	5
ROA Full definition →	15.26%	15.56%	11.46%	10.97%
ROIC Full definition →	15.04%	23.58%	21.83%	18.21%
Return on Tangible Assets Full definition →	82.66%	39.44%	25.61%	26.46%
Average Days of Receivables Full definition →	95.96	90.37	87.64	99.05
Free Cash Flow per Share Full definition →	8.62	8.27	7.52	5.97
Free Cash Flow Full definition →	870.40	831.30	748.70	593.10
Capital Expenditures Full definition →	(27.70)	(32.40)	(34.00)	(43.70)
Other line items
Cash ROIC Full definition →	21.32%	17.60%	15.82%	14.40%
Accounts Receivable Turnover Full definition →	4.55	4.83	4.91	4.44
Accounts Payable Turnover Full definition →	0.11	0.09	0.09	0.09
Inventory Turnover Full definition →	0.86	0.92	0.82	0.74
Average Days of Payables Full definition →	4,238.93	4,976.10	4,723.98	4,982.93
Days of Inventory on Hand Full definition →	546.45	415.21	483.40	590.99
Tax Rate Full definition →	(0.25)	(0.29)	(0.32)	(0.32)
Research and Development Expense of Revenue Full definition →	33.52%	33.80%	35.51%	35.15%
Selling, General and Administrative Expense of Revenue Full definition →	40.06%	38.62%	40.42%	42.58%
Share Based Compensation of Revenue Full definition →	6.95%	7.17%	7.62%	8.41%
Interest Coverage Full definition →	92.42	—	—	—
Operating CF/Net income Full definition →	1.27	1.29	1.64	1.49
Depreciation/Fixed assets Full definition →	0.42	0.19	0.19	0.04
Capex/Depreciation Full definition →	(0.74)	(1.89)	(1.95)	(12.49)
Revenue per Share Full definition →	33.41	30.87	28.75	26.99
Operating CF per Share Full definition →	8.89	8.59	7.87	6.41
Capex per Share Full definition →	(0.27)	(0.32)	(0.34)	(0.44)
Capex to Sales Full definition →	0.01	0.01	0.01	0.02

Show all line items

Columns are period end dates

Stockrow Weekly